{"mainPropery":{"diseaseId":12860,"diseaseName":"Ataxia with Oculomotor Apraxia Type 2","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/12860/ataxia-with-oculomotor-apraxia-type-2","synonyms":["AOA2","SCAN 2","SCAR1","SCAN2","Autosomal recessive spinocerebellar ataxia-1","Ataxia-oculomotor apraxia type 2","Spinocerebellar ataxia with axonal neuropathy type 2"],"synonyms-with-source":[{"name":"AOA2","source":"OrphaData.Org"},{"name":"SCAN 2","source":"OrphaData.Org"},{"name":"SCAR1","source":"OrphaData.Org"},{"name":"SCAN2","source":"Orphanet"},{"name":"Autosomal recessive spinocerebellar ataxia-1","source":"OMIM"},{"name":"Ataxia-oculomotor apraxia type 2","source":"Orphanet"},{"name":"Spinocerebellar ataxia with axonal neuropathy type 2","source":"OMIM"}],"identifiers":[{"identifierType":"OMIM","identifierId":"606002"},{"identifierType":"ORPHANET","identifierId":"64753"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":44,"resourceName":"National Ataxia Foundation","abbreviation":"","address1":"600 Highway 169 South","address2":"Suite 1725","address3":"","address4":"","address5":"","city":"Minneapolis","state":"MN","zip":"55426","country":"United States","phone":"+1-763-553-0020","tty":"","tollFree":"","fax":"+1-763-553-0167","email":"naf@ataxia.org","url":"https://ataxia.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/606002' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='https://ghr.nlm.nih.gov/condition/ataxia-with-oculomotor-apraxia' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Ataxia with Oculomotor Apraxia Type 2. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=64753' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/books/NBK1154/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1892,"resourceId":44,"resourceName":"National Ataxia Foundation","descriptionText":"The <a href='https://ataxia.org/neurologists-and-specialty-clinics/#AtaxiaClinics' target='_blank'>National Ataxia Foundation</a>, a nonprofit organization dedicated to improving the lives of persons affected by ataxia, provides lists of neurologists, ataxia clinics, and movement disorder clinics.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":2076,"resourceId":2843,"resourceName":"Coordination of Rare Diseases at Sanford (CoRDS)","descriptionText":"<a href='http://www.sanfordresearch.org/cords/patientsfamilies/' target='_blank'>Coordination of Rare Diseases at Sanford (CoRDS)</a> hosts a specific registry for patients with ataxia in partnership with the National Ataxia Foundation. The goal of the CoRDS registry is to connect as many patients and researchers as possible to help advance treatments and cures for rare diseases. The CoRDS registry is free for patients to enroll and for researchers to access.","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:606002' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":11885,"questionText":"What is spinocerebellar ataxia with axonal neuropathy type 2?","answerText":"<strong>Spinocerebellar ataxia with axonal neuropathy type 2 (SCAN2)</strong> is a rare condition that affects muscle control and coordination. <a href=\"http://www.mayoclinic.org/diseases-conditions/ataxia/home/ovc-20311863\" target=\"_blank\">Ataxia</a> (difficulty coordinating movements) is&nbsp;generally the earliest sign of the condition and is often diagnosed between age seven and 25 years. Other signs and symptoms may include <a href=\"https://medlineplus.gov/ency/article/000750.htm\" target=\"_blank\">sensorimotor neuropathy</a>, mild cognitive impairment and less commonly, movement disorders. Approximately half of affected people also experience, <a href=\"https://www.aapos.org/terms/conditions/138\" target=\"_blank\">oculomotor apraxia</a> which makes it difficult to move the eyes from side-to side in the desired direction. SCAN2 is caused by changes (mutations) in the <a href=\"https://ghr.nlm.nih.gov/gene/SETX\" target=\"_blank\">SETX</a> gene and is inherited in an autosomal recessive manner.[13472][13465][13466] Treatment is based on the signs and symptoms present in each person.[13465]","dateModified":"2018-09-28T00:00:00"},"basicQuestions":[{"questionId":11896,"questionText":"What are the signs and symptoms of spinocerebellar ataxia with axonal neuropathy type 2?","answerText":"The signs and symptoms of spinocerebellar ataxia with axonal neuropathy type 2 (SCAN2) generally become apparent between age 7 and twenty five years. Ataxia is often the first symptom and is a major cause of disability in the early stages of the condition. Most people with SCAN2 also experience <a href=\"https://medlineplus.gov/ency/article/000750.htm\" target=\"_blank\">sensorimotor neuropathy</a> which is associated with a decreased ability to move or feel (sensation) in certain parts of the body, especially the lower limbs. Other symptoms can include <a href=\"https://www.aapos.org/terms/conditions/138\" target=\"_blank\">oculomotor apraxia</a>, movement disorders, and mild cognitive impairment.[13465][13466][13472]","dateModified":"2017-06-01T15:56:00","resourceClassificationName":"Symptoms","references":[{"referenceId":13465,"authors":"Moreira MC & Koenig M","articleTitle":"Ataxia with Oculomotor Apraxia Type 2","bookWebsiteJournalTitle":"GeneReviews","date":"2018","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1154","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13466,"authors":"","articleTitle":"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1","bookWebsiteJournalTitle":"OMIM","date":"August 2016","volume":"","pages":"","url":"http://www.omim.org/entry/606002","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13472,"authors":"Pera J, Lechner S, Biskup S, Strach M, Grodzicki T, Slowik A","articleTitle":"Two novel mutations of the SETX gene and ataxia with oculomotor apraxia type 2","bookWebsiteJournalTitle":"Clin Neurol Neurosurg","date":"January 2015","volume":"128","pages":"44-46","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11897,"questionText":"What causes spinocerebellar ataxia with axonal neuropathy type 2?","answerText":"Spinocerebellar ataxia with axonal neuropathy type 2 (SCAN2) is caused by changes (mutations) in the <a href=\"https://ghr.nlm.nih.gov/gene/SETX\" target=\"_blank\">SETX</a> gene, which provides instructions for making a protein that is involved in DNA repair. People with a mutation in SETX make a reduced amount of this important protein. This leads to an accumulation of damaged DNA which can cause cells to become unstable and die. Certain cells in the brain, such as those involved in coordinating movements (<a href=\"https://ghr.nlm.nih.gov/art/large/front-view-of-brain.jpeg\" target=\"_blank\">the cerebellum</a>), appear to be most affected by cell death because these cells do not copy themselves to replace cells that have been lost. Scientists suspect that the loss of brain cells in the cerebellum causes the many signs and symptoms associated with SCAN2.[13473]","dateModified":"2017-06-02T14:50:00","resourceClassificationName":"Cause","references":[{"referenceId":13473,"authors":"","articleTitle":"ataxia with oculomotor apraxia","bookWebsiteJournalTitle":"Genetics Home Reference","date":"April 2015","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/ataxia-with-oculomotor-apraxia","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11903,"questionText":"How is spinocerebellar ataxia with axonal neuropathy type 2 inherited?","answerText":"Spinocerebellar ataxia with axonal neuropathy type 2 is inherited in an autosomal recessive manner.[13465] This means that to be affected, a person must have a mutation in both copies of the responsible gene in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a carrier. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\r\n<ul>\r\n    <li>25% (1 in 4) chance to be affected\r\n    </li>\r\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent\r\n    </li>\r\n    <li>25% chance to be unaffected and not be a carrier</li>\r\n</ul>","dateModified":"2017-06-05T14:16:00","resourceClassificationName":"Inheritance","references":[{"referenceId":13465,"authors":"Moreira MC & Koenig M","articleTitle":"Ataxia with Oculomotor Apraxia Type 2","bookWebsiteJournalTitle":"GeneReviews","date":"2018","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1154","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11904,"questionText":"How is spinocerebellar ataxia with axonal neuropathy type 2 diagnosed?","answerText":"A diagnosis of spinocerebellar ataxia with axonal neuropathy type 2 is often suspected based on the presence of characteristic signs and symptoms. Additional testing may then be ordered to confirm the diagnosis and to rule out other conditions that are associated with similar features. This testing may include:[13474][13465]<br />\r\n<ul>\r\n    <li>Imaging studies,&nbsp;such as&nbsp;<a href=\"https://medlineplus.gov/ency/article/003335.htm\" target=\"_blank\">magnetic resonance imaging (MRI)</a></li>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003929.htm\" target=\"_blank\">Electromyography</a></li>\r\n    <li>Special blood tests</li>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003928.htm\" target=\"_blank\">Nerve biopsy</a></li>\r\n    <li>Genetic testing</li>\r\n</ul>","dateModified":"2017-06-05T14:30:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":13465,"authors":"Moreira MC & Koenig M","articleTitle":"Ataxia with Oculomotor Apraxia Type 2","bookWebsiteJournalTitle":"GeneReviews","date":"2018","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1154","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13474,"authors":"Mignarri A, Tessa A, Federico A, Santorelli FM, Dotti MT","articleTitle":"Ataxia with oculomotor apraxia type 2: not always an easy diagnosis","bookWebsiteJournalTitle":"Neurol Sci","date":"August 2015","volume":"36(8)","pages":"1505-1507","url":"https://www.ncbi.nlm.nih.gov/pubmed/25787807","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11905,"questionText":"How might spinocerebellar ataxia with axonal neuropathy type 2 be treated?","answerText":"Although there is no cure for spinocerebellar ataxia with axonal neuropathy type 2 (SCAN2), treatments are available to help manage the signs and symptoms of the condition. For example, affected people may benefit from physical therapy and speech therapy. A wheelchair or other devices may be necessary to help maintain mobility. Children with SCAN2 may also need additional help in school since they may have difficulties with reading, writing and other activities. In some cases, a low-cholesterol diet may be recommended.[13465][13475]","dateModified":"2017-06-05T14:58:00","resourceClassificationName":"Treatment","references":[{"referenceId":13465,"authors":"Moreira MC & Koenig M","articleTitle":"Ataxia with Oculomotor Apraxia Type 2","bookWebsiteJournalTitle":"GeneReviews","date":"2018","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1154","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13475,"authors":"","articleTitle":"Spinocerebellar ataxia with axonal neuropathy type 2","bookWebsiteJournalTitle":"Orphanet","date":"May 2015","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=64753","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":10155,"authors":"Moreira MC & Koenig M","articleTitle":"Ataxia with Oculomotor Apraxia Type 2","bookWebsiteJournalTitle":"GeneReviews","date":"December 8, 2011","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1154/","dateAccessed":"2015-12-04T00:00:00","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[{"relatedDiseaseId":12859,"relatedDiseaseName":"Autosomal Recessive Cerebellar Ataxias","relation":"Parent","isRare":false,"hasGardPage":false}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":8737,"phenoTypeName":"Areflexia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":12160,"phenoTypeName":"Cerebellar vermis atrophy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4518,"phenoTypeName":"Sensorimotor neuropathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":2518,"phenoTypeName":"Elevated alpha-fetoprotein","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13822,"phenoTypeName":"Gait imbalance","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10110,"phenoTypeName":"Gaze-evoked nystagmus","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10133,"phenoTypeName":"Oculomotor apraxia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3053,"phenoTypeName":"Saccadic smooth pursuit","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13594,"phenoTypeName":"Sensory impairment","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13598,"phenoTypeName":"Babinski sign","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8726,"phenoTypeName":"Choreoathetosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5628,"phenoTypeName":"Conjunctival telangiectasia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9421,"phenoTypeName":"Dystonia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10933,"phenoTypeName":"Elevated serum creatine kinase","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11427,"phenoTypeName":"Head tremor","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14568,"phenoTypeName":"Hypercholesterolemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14531,"phenoTypeName":"Hypoalbuminemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13849,"phenoTypeName":"Postural tremor","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10498,"phenoTypeName":"Strabismus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7928,"phenoTypeName":"Urinary bladder sphincter dysfunction","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8731,"phenoTypeName":"Cerebellar atrophy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13706,"phenoTypeName":"Chorea","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5271,"phenoTypeName":"Distal amyotrophy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5216,"phenoTypeName":"Distal muscle weakness","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8703,"phenoTypeName":"Dysarthria","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13455,"phenoTypeName":"Gait ataxia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8725,"phenoTypeName":"Hyporeflexia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":1622,"phenoTypeName":"Impaired distal tactile sensation","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5101,"phenoTypeName":"Impaired proprioception","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13595,"phenoTypeName":"Peripheral axonal neuropathy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":3896,"phenoTypeName":"Pes cavus","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13814,"phenoTypeName":"Scoliosis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9423,"phenoTypeName":"Tremor","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8521,"phenoTypeName":"Abnormal pyramidal sign","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":13638,"phenoTypeName":"Chronic axonal neuropathy","percentRanges":"-"},{"phenoTypeId":13561,"phenoTypeName":"Decreased motor nerve conduction velocity","percentRanges":"-"},{"phenoTypeId":12176,"phenoTypeName":"Impaired distal vibration sensation","percentRanges":"-"},{"phenoTypeId":4825,"phenoTypeName":"Increased circulating antibody level","percentRanges":"-"},{"phenoTypeId":13459,"phenoTypeName":"Limb ataxia","percentRanges":"-"},{"phenoTypeId":8730,"phenoTypeName":"Polyneuropathy","percentRanges":"-"},{"phenoTypeId":12170,"phenoTypeName":"Pontocerebellar atrophy","percentRanges":"-"},{"phenoTypeId":5255,"phenoTypeName":"Progressive","percentRanges":"-"},{"phenoTypeId":13630,"phenoTypeName":"Progressive gait ataxia","percentRanges":"-"},{"phenoTypeId":7381,"phenoTypeName":"Variable expressivity","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Ataxia_with_Oculomotor_Apraxia_Type_2"}